CAR-T clinical trials in China vs commercial treatment

The two routes compared

	Commercial treatment	Clinical trial
Product	NMPA-approved, known characteristics	Investigational; may target newer antigens
Cost	Full list price	Often reduced; some costs borne by the sponsor
Eligibility	Treating hospital’s medical review	Strict protocol criteria — diagnosis, prior lines, organ function
Timing	Scheduled after review	Cohort-dependent; waiting lists are common
Oversight	Standard clinical governance	Protocol + ethics committee + registry reporting

Neither route is automatically better. Commercial treatment buys predictability; trials buy access and price at the cost of constraints.

What trial eligibility actually means for foreigners

Trial protocols are written for a defined population, and many Chinese trials historically enrolled domestic patients. Before investing hope in a specific trial:

• Read the registration. Every legitimate trial has a ClinicalTrials.gov NCT number or a ChiCTR registration. No number, no trial — walk away.
• Ask who the sponsor is and whether the site is the hospital itself or a third party renting its name.
• Ask about residency requirements. Some trials require extended in-country follow-up that makes foreign enrollment impractical.
• Get the eligibility criteria in writing and compare them, point by point, against your records. “You might qualify” from a recruiter is worth nothing against a protocol PDF.

Red flags

The honest version of this page has to say plainly: a market exists that sells “CAR-T clinical trials” to desperate patients. Warning signs:

• Pressure to pay quickly to “hold a slot” in a trial.
• No registration number, or a number that does not match the described study.
• Communication only through messaging apps with an individual, never a hospital department.
• Unwillingness to put eligibility criteria, costs, and exclusions in writing.

Registered trials do not recruit this way.

How Kaimen handles this

Treatment Options in Kaimen Patient OS lists commercial routes and registered trials side by side — each with its documented requirements, timeline, cost basis, source, and last-verified date. Possible and clinician-confirmed options are never mixed: a route becomes “confirmed” only when you record the hospital’s own response.

Start with the Readiness Check, or read the itemized cost picture to compare the two routes financially.